相关实验视频

Updated: Jun 17, 2026

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Therapeutic Gene Delivery and Transfection in Human Pancreatic Cancer Cells using Epidermal Growth Factor Receptor-targeted Gelatin Nanoparticles

Published on: January 4, 2012

双mRNA纳米粒子策略用于增强胰腺癌治疗和β元素组合疗法

Qianru Zhu¹, Chuao Yu¹, Yiquan Chen²

¹Key Laboratory of Elemene Class Anti-Cancer Chinese Medicines, Engineering Laboratory of Development and Application of Traditional Chinese Medicines, Collaborative Innovation Center of Traditional Chinese Medicines of Zhejiang Province, School of Pharmacy, Hangzhou Normal University, Hangzhou, Zhejiang 311121, China.

Proceedings of the National Academy of Sciences of the United States of America

|March 11, 2025

概括

新型mRNA纳米颗粒可以直接向胰腺瘤提供抗PD-1抗体,从而提高新抗原疫苗的有效性. 这种方法增强了抗瘤T细胞的活性,并可能减少胰腺管腺癌 (PDAC) 治疗的全身毒性.

科学领域:

在瘤学瘤学.
免疫学免疫学免疫学
纳米技术纳米技术
生物技术是生物技术.

背景情况:

胰腺管道腺癌 (PDAC) 呈现出显著的免疫抵抗,限制了单剂免疫疗法的疗效.
传统的免疫检查点抑制剂与新抗原疫苗相结合显示出希望,但面临诸如T细胞枯竭和全身毒性等挑战.
新的治疗策略对于克服PDAC治疗中的这些局限性至关重要.

研究的目的:

研究编码抗PD-1抗体的mRNA聚合纳米颗粒在瘤部位的局部抗体生产中的有效性.
评估这种方法作为一种多式免疫疗法与基于新抗原的mRNA疫苗的PDAC多式免疫疗法组合.
评估与常规检查点抑制相关的全身毒性降低潜力.

主要方法:

开发mRNA聚合纳米粒子以在现场生产抗PD-1抗体.
使用这些纳米粒子与基于新抗原的mRNA疫苗进行组合疗法.
在PDAC的临床前模型中评估治疗疗效和免疫反应.

主要成果:

在现场通过mRNA纳米颗粒产生抗PD-1抗体,显著提高了新抗原mRNA疫苗的治疗疗效.
这一策略保护了瘤透的T细胞免受PD-1介导的抑制.
与传统方法相比,局部抗体生产可能会降低系统性毒性.

结论:

双mRNA纳米粒子策略为PDAC中有效的瘤新抗原免疫疗法提供了一种创新方法.
这种基于mRNA的在位抗体生产方法代表了胰腺癌的有前途的组合疗法.
该策略可能与其他经过临床批准的药物兼容,扩大组合治疗选择.

关键词:

这是一种抗PD1的药物.癌症治疗疗法癌症治疗双重mRNA的战略是双重的mRNA.纳米颗粒是一种纳米粒子.新抗原疫苗的新抗原疫苗

更多相关视频

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?

Published on: June 13, 2014

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Sample Extraction and Simultaneous Chromatographic Quantitation of Doxorubicin and Mitomycin C Following Drug Combination Delivery in Nanoparticles to Tumor-bearing Mice

Published on: October 5, 2017

相关概念视频

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...